LIVE

BIO

Bio-Rad Laboratories, Inc.

BIO

NYSE·Healthcare·Medical - Devices·Mkt cap $8.0B

$296.86

-0.08%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$236.73 - $343.12

P/E

48.91

Fwd P/E

31.99

Beta

1.08

Div Yield

0.00%

Avg Vol

379.2K

Shares Out

27.0M

Mkt Cap

$8.0B

Price action

Price chart

Up 18.5% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Comprehensive product portfolio
  • Global distribution network
  • Advanced technological capabilities
  • Strong research and development infrastructure

Bear Case

1 risk

  • Average volatility.

Growth

Stable outlook

Increasing global research investments

Value

Fairly valued vs Life Sciences Tools peers

Momentum

Strong

+6.1% over 3m

Quality

Strong

Excellent business quality

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Apr 29, 2026

Q2 26 RECAP

APR 30, 2026

Reported EPS of $1.89 vs $1.97 consensus (-4.1% surprise). Revenue of $592.1M vs $589.9M expected (+0.4%).

EPS miss
Rev beat +0.4%

EPS surprise · last 4Q

0 of 1 beats

Q2 26

-4.1%

Next: Apr 29, 2026

Revenue trend · last 8Q

-2%

-4%

+2%

+1%

+4%

+1%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$638.5M

$649.7M

$667.5M

$585.4M

$651.6M

$653.0M

$693.2M

$592.1M

Margins · last 8Q

Gross

52.3%

Operating

5.8%

Profit

-89.0%

Wall Street consensus

2 analysts · 0% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

0%

Hold

2

100%

Sell

0%

Median Price Target

$310.00

+4.4% vs $296.86

Low $290.00
Median $310.00
High $320.00

Latest: Wells Fargo · $310.00 · May 25, 2026

2 analysts covering

vs Industry

How BIO stacks vs Medical - Devices

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.